Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Yes, propranolol can slow your heart rate too much, a condition called bradycardia, which is generally flagged when your resting pulse drops below 60 beats per minute and is accompanied by symptoms. Warning signs that the slowdown has become dangerous include dizziness, fainting, unusual fatigue, shortness of breath, chest discomfort, or confusion, and these warrant prompt medical attention. Your risk rises with higher doses, older age, existing heart conduction problems, and combining propranolol with other rate-lowering drugs such as calcium channel blockers or digoxin, and abruptly stopping the medication carries its own separate hazards. Several factors determine whether your specific numbers are concerning or expected, so see below to understand more before making any changes to your dose.
If you are unsure whether your slow pulse and symptoms point to a medication effect or something else, a free, instant, online symptom check can help you organize what you are feeling, understand the most likely explanations, and decide how urgently you should contact your prescriber.
Last reviewed for medical accuracy: 09/14/2026
Propranolol is a non-selective beta-blocker commonly prescribed for high blood pressure, arrhythmias (irregular heartbeats), migraine prevention, essential tremor and anxiety. Like all medications, it carries potential side effects. One of the most important “propranolol side effects” to understand is bradycardia—an abnormally slow heart rate—which in rare cases can become dangerous.
• Propranolol blocks β₁- and β₂-adrenergic receptors, reducing the effects of adrenaline and noradrenaline.
• By dampening β₁-receptor activity in the heart, it slows heart rate (negative chronotropy) and decreases the force of contraction (negative inotropy).
• This reduction in workload can improve control of blood pressure, alleviate angina, quiet certain arrhythmias and reduce the physical symptoms of anxiety.
Because propranolol directly lowers the heart’s pacing signals:
• In healthy hearts, lowering the rate usually poses little risk and may be beneficial.
• If the medication dose is too high, or if a person has underlying conduction disease (for example, sick sinus syndrome or AV block), the heart rate may drop below safe levels.
• Other factors—such as dehydration, electrolyte imbalances, or interactions with other drugs—can compound the effect and precipitate dangerously low rates.
Most people tolerate propranolol well, but certain situations increase the chance of bradycardia becoming problematic:
• High starting doses or rapid dose escalation
• Preexisting slow heart rhythms or electrical conduction problems
• Combined use of other heart-rate lowering drugs (e.g., digoxin, certain calcium channel blockers)
• Hypothyroidism or adrenal insufficiency
• Significant dehydration, vomiting or diarrhea
• Advanced age or frailty
A resting heart rate below 60 beats per minute (bpm) is termed bradycardia, but symptoms and risk depend on how low it goes and whether the body is adapting. Be alert for:
• Dizziness, lightheadedness or fainting (syncope)
• Extreme fatigue or weakness
• Confusion or difficulty concentrating
• Shortness of breath, especially with minimal activity
• Chest pain or discomfort
• Cold, clammy skin
• Low blood pressure (feeling “too weak” or “about to pass out”)
If you experience any of these, especially fainting or chest pain, seek medical help promptly.
To minimize risk of dangerously low heart rate:
• If your pulse is under 50 bpm but you feel fine, contact your prescriber to discuss dose adjustment.
• If you have dizziness, fainting or chest pain, stop the medication and seek emergency care (call 911 or go to the nearest ER).
• For non-urgent concerns, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide if you need immediate evaluation: https://ubiehealth.com/
Propranolol can greatly improve quality of life by controlling blood pressure, reducing migraine frequency and easing anxiety-driven heart palpitations. Yet, balancing its proven benefits with the small risk of bradycardia means:
• Being open with your healthcare team about any side effects.
• Keeping scheduled follow-up visits and heart checks.
• Never adjusting or stopping your dose without medical guidance.
While bradycardia is the most serious, other side effects may occur—most are mild and resolve over time:
• Fatigue or tiredness
• Dizziness or lightheadedness when standing up
• Cold hands and feet
• Digestive issues: nausea, diarrhea or constipation
• Sleep disturbances: vivid dreams or insomnia
• Mild shortness of breath or wheezing (more common in people with asthma)
• Sexual dysfunction (rare and often reversible)
Contact your healthcare provider if you experience:
• Resting pulse under 50 bpm with symptoms
• Recurrent dizziness, fainting or unexplained falls
• New or worsening shortness of breath
• Chest pain, pressure or tightness
• Severe fatigue that interferes with daily activities
• Persistent digestive issues or mood changes
Discuss any lifestyle factors—like high-intensity workouts or diet changes—that might affect how propranolol works for you.
• Take propranolol at consistent times each day, with or without food as directed.
• Avoid sudden stopping—even if you feel well. Abrupt withdrawal may trigger rebound hypertension or worsen angina.
• Limit alcohol, which can enhance heart-rate lowering and cause stronger side effects.
• Read your medication guide and carry a list of your medicines when you travel.
• Propranolol can slow your heart rate. In most people, a mildly lower rate is safe or even beneficial.
• Danger arises if the pulse drops too low (usually under 50 bpm) and you develop symptoms like fainting, chest pain or severe dizziness.
• Regular monitoring, dose adjustments and open communication with your doctor keep you safe.
• Use tools like the free, online symptom check, using the doctor approved Ubie Symptom Checker to gauge when to seek care.
• Always “speak to a doctor” before making any changes to your dose or if you think you might have a life-threatening reaction.
Propranolol remains a widely trusted medication when prescribed and monitored properly. By understanding “propranolol side effects,” especially regarding heart rate, you can take an active role in your own care—staying informed, tracking symptoms and reaching out for help whenever needed.
(References)
* Zoneraich S, Zoneraich O. Life-threatening arrhythmias. Med Clin North Am. 1973 Nov;57(6):1503-14. doi: 10.1016/s0025-7125(16)32205-2. PMID: 4583591.
* Scheinman MM, Hess DS. New antiarrhythmic drugs. Am J Surg. 1983 Jun;145(6):724-32. doi: 10.1016/0002-9610(83)90129-0. PMID: 6407348.
* Sethi BB, Dubé S. Propranolol in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(1):89-99. doi: 10.1016/0278-5846(83)90093-3. PMID: 6682990.
* Joye F. [Beta-blocker intoxication]. Presse Med. 2000 May 20;29(18):1027-33. PMID: 10862260.
* Park YW, Yeom KB, Choi JW, Kim DY, Shin H, Kim KH. Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience. J Dermatolog Treat. 2014 Oct;25(5):391-5. doi: 10.3109/09546634.2012.761667. Epub 2013 Feb 24. PMID: 23273264.
* Logger JGM, Olydam JI, Driessen RJB. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action. J Am Acad Dermatol. 2020 Oct;83(4):1088-1097. doi: 10.1016/j.jaad.2020.04.129. Epub 2020 Apr 29. PMID: 32360760.
* Nagata E, Kashiwagura Y, Okada E, Tanaka S, Sano S, Nishida M, Hayano S, Iwashima S, Hakamata A, Odagiri K, Inui N, Watanabe H, Umemura K, Uchida S. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study. J Pharmacol Sci. 2022 Jun;149(2):60-65. doi: 10.1016/j.jphs.2022.03.004. Epub 2022 Mar 26. PMID: 35512856.
* Bar J, Bar-Ilan E, Cleper R, Sprecher E, Samuelov L, Mashiah J. Monitoring oral propranolol for infantile hemangiomata. Dermatol Ther. 2022 Nov;35(11):e15870. doi: 10.1111/dth.15870. Epub 2022 Oct 11. PMID: 36177767; PMCID: PMC9788279.
* Embaby A, Heinhuis KM, IJzerman NS, Koenen AM, van der Kleij S, Hofland I, van Boven H, Sanders J, van der Graaf WTA, Haas RL, Huitema ADR, van Houdt WJ, Steeghs N. Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio). Eur J Cancer. 2024 May;202:113974. doi: 10.1016/j.ejca.2024.113974. Epub 2024 Mar 2. PMID: 38452721.
* Suarez F, Koyfman A, Long B. Pearls and Pitfalls for the Emergency Clinician: Beta Blocker and Calcium Channel Blocker Toxicity. J Emerg Med. 2026 May;84:1-11. doi: 10.1016/j.jemermed.2026.01.021. Epub 2026 Jan 27. PMID: 41833262.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.